Connect with us

Technology

Nauticus Robotics Announces Results for the Second Quarter of 2024

Published

2 years ago

on

HOUSTON, Aug. 13, 2024 /PRNewswire/ — Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in subsea robotics and software, today announced its financial results for the quarter ended June 30, 2024.

“I would like to thank our existing lenders for their continued support. Their steady conversion of warrants and convertible debentures improve our market cap and reduce our interest burden and our leverage,” said John Gibson, Nauticus’ CEO and President. “We successfully completed Phase I of a program for the largest offshore producer in Brazil. This phase has been billed and collected. We expect to complete Phase II without additional deepwater tests and can execute a significant portion of Phase III while in the Gulf of Mexico this year. We are committed to delivering supervised autonomy to subsea assets during Q3.”

Operational Highlights

Vehicle 2 Testing: Nauticus’ flagship vehicle, Aquanaut Mark 2 (Vehicle 2), underwent planned maintenance this quarter before shipping to Florida Atlantic University (FAU) for open water testing of capabilities refined after the vehicle’s initial Gulf of Mexico (GOM) testing during the first half of the year. The vehicle is planned to ship to Louisiana this month in anticipation of completing qualification testing.

Vehicle 1 Assembly: Vehicle 1 deepwater electronics upgrades are ongoing. Once the vehicle is fully assembled it is planned to ship to FAU to continue development and testing of the next set of vehicle capabilities. Vehicle 1 will become the test and qualification vehicle for these capabilities while Vehicle 2 remains revenue generating. Once new capability qualifications are complete, they will be loaded onto Vehicle 2 to expand Nauticus’ revenue generating opportunities by having two working vehicles with additional capabilities.

Vehicle 3 Assembly: Assembly of Vehicle 3 remains pending. Company focus has been on Vehicles 1 and 2 throughout the quarter.

FAU versus GOM Testing: The partnership with FAU for open water testing allows Nauticus to continue testing Vehicle 2 at a reduced cost compared to GOM open water testing. In addition, FAU provides the team with warehousing and shop facilities to perform minor maintenance as needed. The Atlantic Coast provides multiple deepwater locations close to shore containing bottom artifacts to fully test sensors and capabilities. These benefits will continue with testing of Vehicle 1 once its deepwater upgrades are complete.

Revenue: Nauticus reported second-quarter revenue of $0.5 million, compared to $1.1 million for the prior-year period and $0.5 million for the prior quarter. Q2 includes revenue recognized for the largest South American deepwater operator, an important step in reducing dependence on historical defense revenues.

Operating Expenses: Total expenses during the second quarter were $6.5 million, a $1.5 million decrease from the prior-year period, and a $0.5 million increase from Q1 2024.

Net Income: For the second quarter, Nauticus recorded a net loss of $5.4 million, or basic loss per share of $2.75. This compares with a net income of $20.7 million from the same period in 2023, and a net income of $0.4 million in the prior quarter.

Adjusted Net Loss: Nauticus reported adjusted net loss of $9.0 million for the second quarter, compared to $6.8 million for the same period in 2023. Adjusted net loss is a non-GAAP measure which excludes the impact of certain items, as shown in the non-GAAP reconciliation table below.

2024 G&A Cost: Nauticus reported G&A second-quarter costs of $3.2 million, which is a decrease of $2.3 million compared to the same period in 2023.

Balance Sheet and Liquidity

As of June 30, 2024, the Company had cash and cash equivalents of $8.1 million, compared to $0.8 million as of December 31, 2023.

In Q2, the Company closed additional debt financing of $1 million and raised $9.4 million through an at-the-market equity offering to provide liquidity needed for operations and testing.

Conference Call Details

Nauticus will host a conference call on August 14, 2024 at 10:00 a.m. Central Daylight Time (11:00 a.m. EDT) to discuss its results for the quarter ending June 30, 2024. To participate in the earnings conference call, participants should dial toll free at 800-445-7795, conference ID: KITT, or access the listen-only webcast at the following link: https://events.q4inc.com/attendee/706796022. A link to the webcast will also be available on the Company’s website (https://ir.nauticusrobotics.com/). Following the conclusion of the call, a recording will be available on the Company’s website.

About Nauticus Robotics

Nauticus Robotics, Inc. develops autonomous robots for the ocean industries. Autonomy requires the extensive use of sensors, artificial intelligence, and effective algorithms for perception and decision allowing the robot to adapt to changing environments. The company’s business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus has designed and is currently testing and certifying a new generation of vehicles to reduce operational cost and gather data to maintain and operate a wide variety of subsea infrastructure. Besides a standalone service offering and forward-facing products, Nauticus’ approach to ocean robotics has also resulted in the development of a range of technology products for retrofit/upgrading traditional ROV operations and other third-party vehicle platforms. Nauticus’ services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure. 

Cautionary Language Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Act”), and are intended to enjoy the protection of the safe harbor for forward-looking statements provided by the Act as well as protections afforded by other federal securities laws. Such forward-looking statements include but are not limited to: the expected timing of product commercialization or new product releases; customer interest in Nauticus’ products; estimated operating results and use of cash; and Nauticus’ use of and needs for capital. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These statements may be preceded by, followed by, or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends,” or “continue” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that may cause actual events, results, or performance to differ materially from those indicated by such statements. These forward-looking statements are based on Nauticus’ management’s current expectations and beliefs, as well as a number of assumptions concerning future events. There can be no assurance that the events, results, or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and Nauticus is not under any obligation and expressly disclaims any obligation, to update, alter, or otherwise revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports which Nauticus has filed or will file from time to time with the Securities and Exchange Commission (the “SEC”) for a more complete discussion of the risks and uncertainties facing the Company and that could cause actual outcomes to be materially different from those indicated in the forward-looking statements made by the Company, in particular the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in documents filed from time to time with the SEC, including Nauticus’ Annual Report on Form 10-K filed with the SEC on April 10, 2024. Should one or more of these risks, uncertainties, or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected. The documents filed by Nauticus with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov

 

NAUTICUS ROBOTICS, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

June 30, 2024

December 31, 2023

(Unaudited)

ASSETS

Current Assets:

Cash and cash equivalents

$                    8,122,943

$                       753,398

Restricted certificate of deposit

51,223

201,822

Accounts receivable, net

176,458

212,428

Inventories

2,217,507

2,198,797

Contract assets

482,576

–

Prepaid expenses

1,283,088

1,889,218

Other current assets

490,419

1,025,214

Assets held for sale

289,430

2,940,254

Total Current Assets

13,113,644

9,221,131

Property and equipment, net

16,500,849

15,904,845

Operating lease right-of-use assets

1,380,434

834,972

Other assets

204,296

187,527

Total Assets

$                  31,199,223

$                  26,148,475

LIABILITIES AND STOCKHOLDERS’ DEFICIT

Current Liabilities:

Accounts payable

$                    5,594,270

$                    7,035,450

Accrued liabilities

5,212,935

7,339,099

Contract liability

457,872

2,767,913

Operating lease liabilities – current

420,910

244,774

Total Current Liabilities

11,685,987

17,387,236

Warrant liabilities

1,192,693

18,376,180

Operating lease liabilities – long-term

1,035,713

574,260

Notes payable – long-term, net of discount (related party)

46,644,908

31,597,649

Total Liabilities

$                  60,559,301

$                  67,935,325

Stockholders’ Deficit

Common stock, $0.0001 par value; 625,000,000 shares authorized, 4,131,426
     and 1,389,884 shares issued, respectively, and 4,131,426 and 1,389,884
     shares outstanding, respectively (As adjusted)

$                               413

$                               139

Additional paid-in capital (As adjusted)

94,390,920

77,004,714

Accumulated deficit

(123,751,411)

(118,791,703)

Total Stockholders’ Deficit

(29,360,078)

(41,786,850)

Total Liabilities and Stockholders’ Deficit

$                  31,199,223

$                  26,148,475

 

NAUTICUS ROBOTICS, INC.
Unaudited Condensed Consolidated Statements of Operations

Three Months Ended

Six Months Ended

6/30/2024

3/31/2024

6/30/2023

6/30/2024

6/30/2023

Revenue:

Service

$          501,708

$          464,354

$      1,128,115

$          966,062

$      3,948,395

Service – related party

–

–

–

–

500

Total revenue

501,708

464,354

1,128,115

966,062

3,948,895

Costs and expenses:

Cost of revenue (exclusive of items shown
separately below)

2,875,394

2,093,955

1,900,602

4,969,349

4,832,869

Depreciation

411,586

426,185

53,209

837,771

326,308

Research and development

—

63,534

482,761

63,534

709,728

General and administrative

3,227,288

3,430,010

5,560,565

6,657,298

10,773,209

Total costs and expenses

6,514,268

6,013,684

7,997,137

12,527,952

16,642,114

Operating loss

(6,012,560)

(5,549,330)

(6,869,022)

(11,561,890)

(12,693,219)

Other (income) expense:

Other (income) expense, net

118,274

(96,473)

746

21,801

1,153,127

Gain on lease termination

(8,532)

(15,365)

(3,908)

(23,897)

(3,908)

Foreign currency transaction loss (gain)

4,296

5,147

(17,709)

9,443

(27,593)

Loss on exchange of warrants

–

–

590,266

–

590,266

Change in fair value of warrant liabilities

(4,422,701)

(8,309,623)

(29,668,454)

(12,732,324)

(27,431,550)

Interest expense, net

3,669,423

2,453,372

1,556,597

6,122,795

6,491,664

Total other income, net

(639,240)

(5,962,942)

(27,542,462)

(6,602,182)

(19,227,994)

Net income (loss)

$     (5,373,320)

$          413,612

$    20,673,440

$    (4,959,708)

$      6,534,775

Basic earnings (loss) per share (As adjusted)

$               (2.75)

$                 0.33

$              18.62

$              (2.97)

$                5.90

Diluted earnings (loss) per share (As adjusted)

$               (2.75)

$               (4.06)

$              17.70

$              (2.97)

$                5.79

Basic weighted average shares outstanding (As
adjusted)

1,950,563

1,239,881

1,110,091

1,667,187

1,107,580

Diluted weighted average shares outstanding (As
adjusted)

1,950,563

1,853,967

1,231,814

1,667,187

1,127,853

 

NAUTICUS ROBOTICS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Six Months ended June 30,

2024

2023

Cash flows from operating activities:

Net income (loss)

$         (4,959,708)

$           6,534,775

Adjustments to reconcile net income (loss) to net cash used in operating activities:

Depreciation

837,771

326,308

Amortization of debt discount

3,242,443

1,878,376

Amortization of debt issuance cost

312,440

–

Accretion of RCB Equities #1, LLC exit fee

48,475

–

Stock-based compensation

1,339,965

3,077,027

Loss on exchange of warrants

–

590,266

Change in fair value of warrant liabilities

(12,732,324)

(27,431,550)

Non-cash impact of lease accounting

171,962

145,253

Gain on disposal of assets

(3,102)

–

Write off of property and equipment

29,350

–

Gain on lease termination

(23,897)

–

Gain on short-term investments

–

(40,737)

Changes in current assets and liabilities:

Accounts receivable

35,969

319,940

Inventories

(18,710)

(5,869,092)

Contract assets

(482,576)

(37,341)

Other assets

1,232,368

(1,045,514)

Accounts payable and accrued liabilities

(1,715,646)

8,733,185

Contract liabilities

(2,310,041)

–

Operating lease liabilities

(55,937)

(193,257)

Net cash used in operating activities

(15,051,198)

(13,012,361)

Cash flows from investing activities:

Capital expenditures

(351,942)

(6,102,253)

Proceeds from sale of assets held for sale

419,720

–

Proceeds from sale of property and equipment

6,802

–

Proceeds from sale of short-term investments

–

5,000,000

Net cash from (used in) investing activities

74,580

(1,102,253)

Cash flows from financing activities:

Proceeds from notes payable

14,305,000

–

Payment of debt issuance costs on notes payable

(1,316,791)

–

Proceeds from at-the-market (ATM) offering

9,857,857

–

Payment of at-the-market (ATM) commissions and fees

(499,903)

–

Proceeds from exercise of stock options

–

342,579

Proceeds from exercise of warrants

–

338,055

Net cash from financing activities

22,346,163

680,634

Net change in cash and cash equivalents

7,369,545

(13,433,980)

Cash and cash equivalents, beginning of year

753,398

17,787,159

Cash and cash equivalents, end of year

$           8,122,943

$           4,353,179

NAUTICUS ROBOTICS, INC.
Unaudited Reconciliation of Net Income (Loss) Attributable to Common Stockholders (GAAP) to Adjusted Net Loss
 Attributable to Common Stockholders (NON-GAAP)

Adjusted net loss attributable to common stockholders is a non-GAAP financial measure which excludes certain items that are included in net income (loss) attributable to common stockholders, the most directly comparable GAAP financial measure. Items excluded are those which the Company believes affect the comparability of operating results and are typically excluded from published estimates by the investment community, including items whose timing and/or amount cannot be reasonably estimated or are non-recurring.

Adjusted net loss attributable to common stockholders is presented because management believes it provides useful additional information to investors for analysis of the Company’s fundamental business on a recurring basis. In addition, management believes that adjusted net loss attributable to common stockholders is widely used by professional research analysts and others in the valuation, comparison, and investment recommendations of companies such as Nauticus.

Adjusted net loss attributable to common stockholders should not be considered in isolation or as a substitute for net income (loss) attributable to common stockholders or any other measure of a company’s financial performance or profitability presented in accordance with GAAP. A reconciliation of the differences between net income (loss) attributable to common stockholders and adjusted net loss attributable to common stockholders is presented below. Because adjusted net loss attributable to common stockholders excludes some, but not all, items that affect net income (loss) attributable to common stockholders and may vary among companies, our calculation of adjusted net loss attributable to common stockholders may not be comparable to similarly titled measures of other companies.

Three Months Ended

Six Months Ended

6/30/2024

3/31/2024

6/30/2023

6/30/2024

6/30/2023

Net income (loss) attributable to common stockholders
(GAAP)

$  (5,373,320)

$        413,612

$  20,673,440

$  (4,959,708)

$    6,534,775

Change in fair value of warrant liabilities

(4,422,701)

(8,309,623)

(29,668,454)

(12,732,324)

(27,431,550)

Stock compensation expense

809,310

432,053

1,214,863

1,339,965

3,077,027

Sales and use tax assessment

–

–

–

–

1,189,164

Loss on exchange of warrants

–

–

590,266

–

590,266

Interest and penalties on RRA Amendment

–

–

362,045

–

4,320,690

Adjusted net loss attributable to common stockholders
(non-GAAP)

$  (8,986,711)

$   (7,463,958)

$  (6,827,840)

$  (16,352,067)

$  (11,719,628)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nauticus-robotics-announces-results-for-the-second-quarter-of-2024-302221750.html

SOURCE Nauticus Robotics, Inc.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Melanie Siewert, Chief Marketing Officer at LHH, Joins the Exceptional Women Alliance (EWA)

Published

2 hours ago

on

May 8, 2026

By

LOS ANGELES, May 8, 2026 /PRNewswire/ — The Exceptional Women Alliance (EWA) proudly welcomes Melanie Siewert, Chief Marketing Officer at LHH, into its distinguished community of influential women leaders. A seasoned global marketing executive, Siewert brings more than 20 years of experience transforming brands, building high-performing teams, and driving measurable growth across both B2B and B2C industries.

As Chief Marketing Officer of LHH, Siewert leads global marketing strategy across brand, demand generation, and customer experience. She plays a critical role in aligning marketing with business objectives and fostering strong collaboration with sales to enhance organizational performance and accelerate growth. Her leadership has been instrumental in shaping a modern, customer-centric brand and building a marketing function designed to deliver consistent, high-impact results across a complex global enterprise.

Throughout her career, Siewert has held senior leadership roles at prominent organizations including Truist Financial, Worldpay, Equifax, Whirlpool Corporation, and JPMorgan Chase. She is widely recognized for guiding enterprise brand strategy, leading complex mergers, scaling marketing operations, and delivering measurable gains in pipeline, revenue, and digital adoption.

Siewert’s expertise spans marketing strategy, customer engagement, brand development, sales enablement, and cross-functional leadership. Known for her empowering leadership style and strategic vision, she consistently builds high-performing teams that drive sustainable business growth while fostering collaboration and innovation.

Her accomplishments include:

Leading global marketing strategy for LHH, integrating brand, demand generation, and customer experience to drive business performance.Guiding enterprise brand transformations and go-to-market strategies across multiple global organizations.Driving measurable growth in pipeline, revenue, and digital engagement through data-driven marketing initiatives.Leading marketing efforts through complex mergers and organizational transformations.Serving as a two-time board chair and lifetime member of Strategic & Competitive Intelligence Professionals.Recognized as a Top Woman in Marketing by PRWeek.

“Melanie’s ability to translate complex market dynamics into clear, impactful strategies, combined with her commitment to building strong, collaborative teams, makes her an exceptional addition to EWA,” said Larraine Segil. “Her leadership and results-driven approach align seamlessly with the values of our sisterhood.”

Melanie shared “I’m honored to be part of the Exceptional Women’s Alliance and look forward to learning from the incredible women leaders who are dedicated to lifting other women and impacting the world at large.”

Siewert now joins a powerful and growing community of C-suite and board-level women leaders across disciplines who share a common goal: to support one another through confidential, life-long mentoring relationships and to enrich both their professional and personal lives.

About Exceptional Women Alliance (EWA)
The Exceptional Women Alliance (EWA) is an invitation-only peer mentorship organization where high-level Exceptional Women from across multiple industries are hand-selected and invested in, to grow, learn, share, and succeed. In addition to the achievement of significant success, the criteria for acceptance include character traits that are defining of the EWA Culture – Kindness, the Spirit of Generosity, Transparency, Gratitude, and Willingness to Share their knowledge. The Foundation is a powerhouse of peer-to-peer mentoring that provides guidance, deep connection, and leadership, propelling each woman to sustainable success—one woman at a time. The life-long program enables each participant to be connected as alumnae in the ever-expanding EWA global community, as their fellow women leaders continue to move into positions of significance.

Learn more at www.exceptionalwomenalliance.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/melanie-siewert-chief-marketing-officer-at-lhh-joins-the-exceptional-women-alliance-ewa-302767205.html

SOURCE Exceptional Women Alliance

Continue Reading

Technology

Insurance Modernization at Risk as Workforce Strategies Fall Behind, Says Info-Tech Research Group

Published

3 hours ago

on

May 8, 2026

By

Insurers are under pressure to modernize core systems while competing for scarce cloud, data, AI, and cybersecurity talent. Info-Tech Research Group’s new blueprint, Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance, outlines a practical framework to help insurance IT and HR leaders assess readiness, strengthen their employee value proposition, and retain the critical roles needed to accelerate transformation.

ARLINGTON, Va., May 8, 2026 /PRNewswire/ – Insurance modernization is increasingly being constrained by the people and capabilities required to deliver it, according to Info-Tech Research Group. The global research and advisory firm’s newly published blueprint, Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance, provides a structured approach to help insurers attract, retain, and mobilize the IT talent required to support digital transformation.

The firm’s research indicates that many insurers are trying to advance core system modernization while facing shortages in cloud, data, AI, and cybersecurity roles. At the same time, experienced legacy system experts are retiring, creating knowledge gaps that can slow delivery, increase operational risk, and deepen dependence on external partners.

“Insurance modernization cannot succeed if the workforce strategy behind it remains outdated,” says Vidhi Trivedi, senior research analyst at Info-Tech Research Group. “Insurers need an employee value proposition that reflects what both digital and legacy talent value today: flexibility, growth, purpose, and belonging. When organizations connect those expectations to the technology roadmap, they are better positioned to retain institutional knowledge, attract new capabilities, and move transformation forward with confidence.”

Key Workforce Risks Slowing Insurance Modernization

Info-Tech’s blueprint identifies several talent challenges that are limiting insurers’ ability to modernize effectively:

Critical digital skills remain difficult to attract and retain. Cloud engineers, data architects, cybersecurity specialists, and AI-capable technologists are essential to future-state systems, integration, and automation.Legacy expertise is leaving faster than it can be replaced. Core system knowledge remains vital to operations, compliance, and transition planning, yet many long-tenured experts are approaching retirement or feel disconnected from future-state roles.Rigid work models reduce access to high-demand talent. Digital professionals increasingly expect hybrid options, autonomy, modern delivery practices, and environments that support productivity and wellbeing.Growth pathways are not clearly connected to transformation needs. Without structured upskilling, internal mobility, and role progression, insurers risk losing employees to industries perceived as more innovative or career-accelerating.Employer branding often undersells insurance’s purpose and impact. The industry plays a critical role in protecting people, businesses, and communities, but that purpose is not always translated into a compelling technology career story.

Info-Tech’s Three-Phase Framework for Rebuilding the Insurance IT Talent Engine

To help insurers address these challenges, the Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance blueprint outlines a three-phase methodology:

Assess Talent Readiness for Modernization Success
Insurance IT and HR leaders identify modernization-critical roles, evaluate workforce pressure, assess EVP fit across key roles, and prioritize the roles that pose the greatest risk to transformation timelines.Build and Embed a Modern Employee Value Proposition
Organizations define a clear employer-employee value exchange, establish proof points across the four EVP pillars of flexibility, growth, purpose, and belonging, and activate targeted initiatives for priority roles.Develop and Present the EVP Impact Report
Leaders synthesize workforce insights, visualize progress, and present a measurable view of how EVP activation is improving retention, engagement, internal mobility, and readiness.

The resource also includes supporting tools, such as the EVP Diagnostic Tool, EVP Activation & Implementation Tool, and EVP Impact Report Template, that help insurers move from talent planning to measurable action.

“Too often, insurers view IT talent challenges as a capacity issue, when they are really a transformation risk,” explains Trivedi. ” “The insurers that move fastest will be those that know where critical capabilities are under strain, protect the expertise that increases operational resilience, and create clear pathways for employees to help shape the future of insurance from within.”

By applying Info-Tech’s framework outlined in the Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance blueprint, insurance leaders can better understand where people-related risks are highest, strengthen retention in critical roles, reduce long-term reliance on external partners, and build a more resilient technology organization. The firm’s research emphasizes that a modern EVP is not only an HR initiative but a strategic enabler of modernization success.

For exclusive and timely commentary from Info-Tech’s experts, including Vidhi Trivedi, and access to the complete Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance blueprint, please contact pr@infotech.com.

About Info-Tech Research Group

Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.

To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.

Media professionals can register for unrestricted access to research across IT, HR, and software, and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.

For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/insurance-modernization-at-risk-as-workforce-strategies-fall-behind-says-info-tech-research-group-302767354.html

SOURCE Info-Tech Research Group

Continue Reading

Technology

Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization

Published

4 hours ago

on

May 8, 2026

By

IRVING, Texas, May 8, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced that it has submitted an application to the New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation Program (CLEP), administered through the Wadsworth Center, seeking authorization to perform Caris Assure®, its blood‑based molecular profiling test, on specimens originating from New York State.

Caris Assure is a blood‑based molecular profiling test designed to support comprehensive biomarker analysis using a minimally invasive blood sample. Caris Assure uses circulating nucleic acids sequencing (cNAS) to analyze the whole exome (DNA) and whole transcriptome (RNA) of 22,000 genes. This comprehensive test identifies tumor alterations, clonal hematopoiesis (CH) and inherited variants, pharmacogenomic alterations, microsatellite instability (MSI) and tumor mutational burden (TMB).

The submission initiates the formal review process required by New York State for clinical laboratories seeking to perform testing on specimens collected from New York patients. Through the Wadsworth Center, CLEP conducts comprehensive reviews of laboratory permits and laboratory-developed tests to evaluate analytical validation, quality systems, personnel qualifications and compliance with applicable state regulations.

“Caris is committed to meeting the highest standards for laboratory quality, validation and regulatory compliance,” said David Spetzler, MS, PhD, MBA, President of Caris Life Sciences. “This submission of Caris Assure for review through the New York State Department of Health’s Wadsworth Center reflects our disciplined approach to expanding access to our technologies in a manner that demonstrates the rigor, responsibility and focus on the patient that define Caris Life Sciences and guide our work in the markets we serve.”

At this time, no determination has been made by NYSDOH, and Caris Assure is not authorized for use on blood-based specimens originating from New York State unless and until CLEP authorization is granted.

Caris operates a CAP-accredited, CLIA‑certified clinical laboratory and performs testing in jurisdictions where it is authorized to do so, in accordance with all applicable federal, state, and local regulations. Any future availability of Caris Assure in New York State will be contingent upon completion of the CLEP review process administered by the Wadsworth Center and receipt of the appropriate authorization.

About Caris Life Sciences
Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Genome, Whole Exome and Whole Transcriptome Sequencing), advanced AI and machine learning, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies and high-performance computing provides a differentiated platform for developing the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development.

Caris was founded with a vision to realize the potential of precision medicine to improve the human condition. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S. and other international markets.

Forward Looking Statements

This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical facts contained in this press release are forward-looking statements, including statements regarding our business, solutions, plans, objectives, goals, industry trends, financial outlook and guidance. In some cases forward-looking statements can be identified by words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “potential,” “contemplate,” “believe,” “estimate,” “predict,” or “continue” or similar expressions.

You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in these forward-looking statements are reasonable based on information currently available to us, we cannot guarantee that the future results, discoveries, levels of activity, performance or events and circumstances reflected in forward-looking statements will be achieved or occur. Forward-looking statements involve known and unknown risks and uncertainties, some of which are beyond our control. Risks and uncertainties that could cause our actual results to differ materially from those indicated or implied by the forward-looking statements in this press release include, among other things: our future financial performance, results of operations or other operational results or metrics; development, analytical and clinical validation, timing and performance of future solutions by us and our competitors; commercial market acceptance for our solutions, including acceptance of preventive as well as diagnostic testing paradigms, and our ability to meet resulting demand; the rapidly evolving competitive environment in which we operate; third-party payer reimbursement and coverage decisions related to our solutions; risks related to data management, storage, and processing capabilities and our ability to integrate and deploy artificial intelligence and advanced data analytics technologies; our ability to protect and enhance our intellectual property; regulatory requirements, decisions or approvals (including the timing and conditions thereof) related to our solutions, including our application for New York State Department of Health approval for Caris Assure; reliance on third-party suppliers; risks related to data security, patient privacy, and compliance with healthcare data protection regulations as well as potential cybersecurity threats to our data platforms; our compliance with laws and regulations; the outcome of government investigations and litigation; risks related to our indebtedness; and our ability to hire and retain key personnel as well as risks, uncertainties; and other factors described in the section titled “Risk Factors” and elsewhere in our Annual Report on Form 10-K filed on March 3, 2026, and in our other filings we make with the SEC from time to time. We undertake no obligation to update any forward-looking statements to reflect changes in events, circumstances or our beliefs after the date of this press release, except as required by law.

Caris Life Sciences Media:
Corporate Communications
CorpComm@CarisLS.com
214.294.5606 

View original content to download multimedia:https://www.prnewswire.com/news-releases/caris-life-sciences-submits-application-to-new-york-state-department-of-health-for-caris-assure-bloodbased-testing-authorization-302767104.html

SOURCE Caris Life Sciences

Continue Reading

Trending